APOLLO HOSPITALS ENTER. L vs KWALITY PHARMACEUTICALS L

A side-by-side comparison of APOLLO HOSPITALS ENTER. L (APOLLOHOSP) and KWALITY PHARMACEUTICALS L (KPL) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, KWALITY PHARMACEUTICALS L leads APOLLOHOSP vs KPL on 9 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

Valuation

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

65.36
P/E ratio
41.63
13.42
P/B ratio
8.58
0.11%
Dividend yield
0.00%
₹135.04
EPS
₹64.91

Profitability

How efficiently each company turns capital and sales into profit. Higher is better.

22.10%
Return on equity
22.80%
18.00%
Return on capital
24.00%
15.00%
EBITDA margin
24.00%
7.94%
Net margin
13.32%

Growth

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

14.94%
Revenue CAGR (3Y)
26.08%
33.39%
Profit CAGR (3Y)
52.21%

Size & financial health

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹1.27L Cr
Market cap
₹2,812 Cr
₹25,228 Cr
Revenue
₹503 Cr
₹2,003 Cr
Net profit
₹67 Cr
0.90
Debt / equity
0.00
APOLLO HOSPITALS ENTER. L
  • + ["Company has delivered good profit growth of 77.8% CAGR over last 5 years", "Company has been maintaining a healthy dividend payout of 17.7%"]
  • ["Stock is trading at 13.4 times its book value", "Company might be capitalizing the interest cost"]
KWALITY PHARMACEUTICALS L
  • + ["Company is expected to give good quarter", "Company has delivered good profit growth of 35.0% CAGR over last 5 years", "Company has a good return on equity (ROE) track record: 3 Years ROE 18.2%", "Company's median sales growth is 27.4% of last 10 years"]
  • ["Stock is trading at 8.13 times its book value", "Though the company is reporting repeated profits, it is not paying out dividend", "Company has high debtors of 203 days."]
APOLLO HOSPITALS ENTER. L full analysis KWALITY PHARMACEUTICALS L full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.